Tag: Indian Pharmaceuticals Exempted from Additional US Tariffs

Indian Pharmaceuticals Exempted from Additional US Tariffs

Dose daily

Dose Daily News Bureau - August 13, 2025

Indian Pharmaceuticals Exempted from Additional US Tariffs PharmaGenDRx News Bureau - 13th August, 2025 10:00 AM IST The Government recently clarified that no additional tariffs have been...

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

Dose Daily News Bureau - June 3, 2026

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Breaking News

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

Breaking News

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

Breaking News

Top 15 Pharmacy Colleges in West Bengal: Complete Guide for Pharmacy Aspirants (2026)

Career & Exams

Kwality Wall’s to Serve Only Milk-Based Ice Cream in India by 2027

Breaking News

Tag: Indian Pharmaceuticals Exempted from Additional US Tariffs

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

Top 15 Pharmacy Colleges in West Bengal: Complete Guide for Pharmacy Aspirants (2026)

Kwality Wall’s to Serve Only Milk-Based Ice Cream in India by 2027

Follow us

Categories

Latest news

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

Popular news

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

Lupin’s Ankleshwar Plant Secures US FDA EIR

Anupam Rasayan is Preparing to Acquire 43% Stake in Bliss GVS Pharma for Around ₹1,369 Crore